Case Comprehensive Cancer Center: Pancreatic Neoplasms trials
The registry lists 15 Pancreatic Neoplasms studies with Case Comprehensive Cancer Center as lead sponsor. 4 are open to participants now and 3 have results posted.
Early Phase 1 1Phase 1 2Phase 2 3Phase 3 1No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE)Not yet recruitingNCT07653594Not applicable
- Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac PainRecruitingNCT07117032Phase 1
- EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.RecruitingNCT06263088Not applicable
- Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?RecruitingNCT05720338Phase 3
- Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II StudyTerminatedNCT02345460Phase 2Results posted
- KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic CancerCompletedNCT02337465Not applicableResults posted
- Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic CancerCompletedNCT01666730Phase 2Results posted
- CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X)WithdrawnNCT06110598Phase 2
- Multidimensional Prehabilitation in Pancreatic Surgery for Pancreatic and Periampullary NeoplasmsCompletedNCT05225038Not applicable
- Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic CancerCompletedNCT02153450Early Phase 1
- Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by SurgeryWithdrawnNCT01954732Phase 1
- Biological Markers in Patients With Pancreatic Cancer Experiencing Weight LossCompletedNCT00899158
- Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic CancerTerminatedNCT00899132
- Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their CaregiversCompletedNCT00684801
- Changes in Muscle Tissue in Patients With Pancreatic CancerCompletedNCT00369460